Upon the completion of the merger, stockholders of Ocular (NASDAQ: OCLR) will receive 0.3879 of a share of Cooper (NYSE: COO) common stock and $22 in cash for each share of Ocular common stock that they own. The transaction is expected to close in the first quarter of Cooper's 2005 fiscal year, which began on Nov. 1.
Completion of the merger remains subject to antitrust clearance by the U.S. Federal Trade Commission. Both companies make contact lenses. Upon completion, the new entity would be the world's third largest contact lens company.